COMPLETED

Philly NavSTAR Implementation Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Patient Navigation (PN) interventions following hospitalization can reduce the differences that certain groups have been trying to access opioid use disorder treatment. These differences, which affect racial minority groups the most, contribute to the opioid overdose epidemic. However, delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to find solutions to these significant barriers by engaging community, hospital, and patient partners. This study is being conducted to learn more about how to implement NavSTAR, a patient navigation intervention for people with opioid use disorder, across a health system. Our research team showed in a previous study with 400 participants that NavSTAR significantly increased entry into opioid use disorder treatment, reduced readmissions to the hospital, and was highly cost- effective compared to treatment as usual. This study will first pilot NavSTAR with 32 patient participants across 4 hospitals in the City of Philadelphia. Then, we will conduct a large trial with 720 patient participants to see if we can reach people who need the intervention, and create a sustainable plan to continue the intervention after the grant award period.

Official Title

Implementing a Patient Navigation Intervention Across a Health System to Address Treatment Entry Inequities

Quick Facts

Study Start:2024-08-09
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06634277

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. age 18 or older;
  2. 2. current DSM-5 criteria for moderate to severe OUD;
  3. 3. willing and able to provide informed consent in English.
  1. 1. enrollment in OUD treatment 30-days prior to hospitalization;
  2. 2. residency outside the City of Philadelphia;
  3. 3. pregnancy;
  4. 4. planned discharge to a long-term inpatient care facility (e.g., hospice);
  5. 5. hospitalization for a suicide attempt.

Contacts and Locations

Principal Investigator

Karen Alexander, PhD
PRINCIPAL_INVESTIGATOR
Friends Research Institute, Inc.
Jan Gryczynski, PhD
PRINCIPAL_INVESTIGATOR
Friends Research Institute, Inc.

Study Locations (Sites)

Jefferson Health
Philadelphia, Pennsylvania, 19107
United States
Friends Research Institute
Philadelphia, Pennsylvania, 19125
United States

Collaborators and Investigators

Sponsor: Friends Research Institute, Inc.

  • Karen Alexander, PhD, PRINCIPAL_INVESTIGATOR, Friends Research Institute, Inc.
  • Jan Gryczynski, PhD, PRINCIPAL_INVESTIGATOR, Friends Research Institute, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-09
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2024-08-09
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • patient navigation

Additional Relevant MeSH Terms

  • Opioid Use Disorder